


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.52%
-2.56%
-0.38%
-0.26%
-2.07%
DOCS
Doximity
$41.10
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Investors confidence is positive

Outperform the market
Risk Analysis

Trading above its fair value
DOCS Price Performance
$43.65 (-5.84%)
$66.25 (-37.96%)
$67.08 (-38.73%)
$58.75 (-30.04%)
DOCS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading above its fair value

Outperform the market
![]()
DOCS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
DOCS Street Sentiment is extremely bullish and have positive views on the near-term outlook
DOCS has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
What is DOCS current stock price?
What are DOCS stock strengths?
What is DOCS Risk Level?
What is DOCS market cap and volume?
What is DOCS current Stock IQ?
Should I buy DOCS stock right now?
Is DOCS a Strong Buy right now?
What does a 'Strong Buy' rating mean for DOCS?
What does a 'Strong Sell' rating mean for DOCS?
What factors influence DOCS's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-1.52%
-2.56%
-0.38%
-0.26%
-2.07%
DOCS
Doximity
Current Price
$41.10
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Investors confidence is positive

Outperform the market
Risk Analysis

Trading above its fair value
Recently Viewed
DOCS
Doximity
41.10
-0.39%
CADE
Cadence Bancorporation
44.50
-0.02%
EFOI
Energy Focus Inc.
2.47
-4.63%
CRVL
CorVel Corp.
69.27
+0.99%
EGBN
Eagle Bancorp Inc
22.50
-1.49%

DOCS Price Performance
$43.65 (-5.84%)
$66.25 (-37.96%)
$67.08 (-38.73%)
$58.75 (-30.04%)
DOCS Analysts Opinion
DOCS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading above its fair value

Outperform the market
![]()
DOCS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
DOCS Street Sentiment is extremely bullish and have positive views on the near-term outlook
DOCS has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
Dec 15, 2025
Upgrade
Overweight
Morgan Stanley
Dec 10, 2025
Initiate
Overweight
Barclays
Nov 22, 2025
Upgrade
Strong
Raymond James
Nov 07, 2025
Reiterate
Outperform
Evercore ISI
Oct 27, 2025
Upgrade
Buy
B of A Securities
DOCS Stock IQ
DOCS Latest Analysis
RSI Alert: Doximity (DOCS) Now Oversold. Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me
Wed Jan 14, 2026
Heres Why Doximity (DOCS) is a Strong Growth Stock. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Mon Jan 12, 2026
Doximity (DOCS) Slid on Renewed Volatility. ClearBridge Investments an investment management company released its ClearBridge Growth Strategy fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. US equities reported a strong but volatile performance in the fourth quarter with the S&.P 500 Index returning 2.7% while the benchmark Russell Midcap Growth Index declined 3.7%. In this environment a [….]
Mon Jan 12, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
DOCS Stock trends
DOCS Stock performance
DOCS Stock analysis
DOCS investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.